ARMIS BIOPHARMA, INC.

Profile

Company Names

ARMIS BIOPHARMA, INC.
CHD BIOSCIENCE, INC.

Addresses

2401 RESEARCH BLVD, SUITE 205, FORT COLLINS, CO 80526

2950 EAST HARMONY, SUITE 252, FORT COLLINS, CO 80528

Phone Numbers

970-295-4373

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE, OTHER

Year Incorporated:

> 5 years ago

State Incorporated:

COLORADO

Total Amount Raised:

$21,162,120.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2025-06-27 
$1,000,000.00 
$3,000,000.00 
$2,000,000.00 
Equity 
7
2020-05-15 
$7,270,000.00 
$10,000,000.00 
$2,730,000.00 
 
6
2018-06-22 
$1,832,300.00 
$10,000,000.00 
$8,167,700.00 
Equity 
5
2017-10-30 
$125,000.00 
$30,000,000.00 
$29,875,000.00 
Equity 
4
2017-02-16 
$2,744,835.00 
$14,000,000.00 
$11,255,165.00 
Equity 
3
2016-01-27 
$3,255,561.00 
$5,799,999.00 
$2,544,438.00 
Equity 
2
2015-03-16 
$1,736,920.00 
$1,736,920.00 
$0.00 
Equity 
1
2014-02-07 
$3,197,504.00 
$3,197,504.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROY, JR. 
 
CARVER 
DIRECTOR
ROY 
 
CARVER, JR. 
DIRECTOR
DOUG 
 
CODER 
DIRECTOR
DOUGLAS 
 
CODER 
DIRECTOR
STEPHEN 
 
CODER 
DIRECTOR
STEVE 
 
CODER 
EXECUTIVE OFFICER, DIRECTOR
MICHAEL 
 
HANDLEY 
EXECUTIVE OFFICER, DIRECTOR
ROBERT 
 
KALI 
EXECUTIVE OFFICER
MICHAEL 
 
LITWACK 
DIRECTOR
LORETTA 
 
MEALY 
DIRECTOR
ED 
 
NEAS 
DIRECTOR, EXECUTIVE OFFICER
ED 
 
NEAS, PH.D. 
DIRECTOR
WILLIAM 
 
NELSON, MD, PH.D. 
DIRECTOR
WILLIAM 
 
NELSON, MD. PH.D. 
DIRECTOR
WILLIAM 
 
NELSON, V 
DIRECTOR
CHRISTOPHER 
 
RUDD 
DIRECTOR
ALAN 
 
RUUD 
DIRECTOR
CHRISTOPHER 
 
RUUD 
EXECUTIVE OFFICER, DIRECTOR
ALAN 
 
SMITH, PH.D. 
DIRECTOR
CATHY 
 
SOHN 
DIRECTOR
DENNIS 
 
TEMPLAR 
EXECUTIVE OFFICER, DIRECTOR
MICHAEL 
 
VOSS 
EXECUTIVE OFFICER, DIRECTOR
TED 
 
ZIEMANN 
EXECUTIVE OFFICER, DIRECTOR
THEODORE 
 
ZIEMANN 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2025-06-27 
D/A
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
 
2020-05-15 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
 
2020-05-15 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-22 
D/A
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2017-02-16 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2017-10-30 
D/A
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2017-02-16 
D/A
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2016-01-27 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2016-01-27 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2015-03-16 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2014-02-07 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2014-02-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
ARETE WEALTH MANAGEMENT, LLC
NONE
NONE
CG CAPITAL MARKETS LLC
NONE
NONE
TORREYA CAPITAL
NONE
NONE
PRECISION SECURITIES, LLC
NONE
NONE
APPLIED CAPITAL, LLC
DONENFELD, ALAN PAUL
BRISTOL INVESTMENT GROUP, INC.